Marc Carrier , MD, MSc
mcarrier@toh.on.ca
Scientist, Clinical Epidemiology, Ottawa Hospital Research InstitutePhysician, Hematology (Thrombosis), The Ottawa Hospital
Associate Professor, Department of Medicine, Faculty of Medicine, and Research Chair in Venous Thromboembolism and Cancer (Tier 2) at the University of Ottawa
Research Interests
Dr. Carrier's clinical research is focused in venous thromboembolic disease and cancer, including cancer screening, prevention and management. Dr. Carrier is currently the Principal Investigator on three peer-reviewed clinical trials (Heart and Stroke Foundation (1) and Canadian Institute of Health Research (2)) and numerous industry sponsored trial. Dr. Carrier has published important systematic reviews and has had multiple international speaking invitations to speak on the topics of cancer and thrombosis.
Most Recent Publications (provided by The Ottawa Hospital Library Database)
Carrier M;Rodger M;Wells PS;Righini M;Le GG;, (2011 Mar 7), Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: A systematic review and meta-analysis, J Thromb Haemost , -> view abstract
Carrier M;Le GG;Tay J;Wu C;Lee AY;, (2011 Jan 21), Rates of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide or Lenalidomide: A Systematic Review and Meta-Analysis, J Thromb Haemost , -> view abstract
Gandara E;Bose G;Erkens P;Rodgers M;Carrier M;Wells P;, (2011 Jan 13), Outcomes of saddle pulmonary embolism: a nested case-control study, J Thromb Haemost ,
Le GG;Carrier M;Kovacs MJ;Betancourt MT;Kahn SR;Wells PS;Anderson DA;Chagnon I;Solymoss S;Crowther M;Righini M;Delluc A;White RH;Vickars L;Rodger M;, (2011 Feb 16), Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study, J Thromb Haemost , -> view abstract
Carrier M;Le GG;Tao H;Wells PS;Danovitch K;Mbanga-levac A;Rodger M;, (2010 Oct), Should we screen patients with unprovoked venous thromboembolism for occult cancers? A pilot study, Blood Coagul Fibrinolysis , Vol.21, Issue 7, 709-710
Carrier M;Le GG;Wells PS;Rodger MA;, (2010 May 4), Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism, Ann Intern Med, Vol.152, Issue 9, 578-589 -> view abstract
Carrier M;Righini M;Wells PS;Perrier A;Anderson DR;Rodger MA;Pleasance S;Le GG;, (2010 Jun 7), Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies, J Thromb Haemost, Vol.8, Issue 8, 1716-1722 -> view abstract
Rodger MA;Le GG;Carrier M;Betancourt MT;Kahn SR;Wells PS;Anderson DA;Lacut K;Chagnon I;Solymoss S;Crowther M;Perrier A;White R;Vickars L;Ramsay T;Kovacs MJ;, (2010 Jun 26), Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE, Thromb Res, Vol.126, Issue 3, 222-226 -> view abstract
Le GG;Kovacs MJ;Carrier M;Do K;Kahn SR;Wells PS;Anderson DA;Chagnon I;Solymoss S;Crowther M;Righini M;Lacut K;White RH;Vickars L;Rodger M;, (2010 Jun 10), Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study, Thromb Haemost, Vol.104, Issue 3, 498-503 -> view abstract
Rodger M;Carrier M;Gandara E;Le GG;, (2010 Jul 13), Unprovoked Venous Thromboembolism: Short term or Indefinite Anticoagulation? Balancing Long-Term Risk and Benefit, Blood Rev, Vol.24, Issue 5-Apr, 171-178 -> view abstract
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
